HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 282, Issue 48, 35405-35415, November 30, 2007

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 282/48/35405    most recent M705814200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pilecka, I. Articles by van Huijsduijnen, R. H. Search for Related Content PubMed PubMed Citation Articles by Pilecka, I. Articles by van Huijsduijnen, R. H. Social Bookmarking                      What's this?

Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth^*

Iwona Pilecka¹, Claudia Patrignani, Rosanna Pescini, Marie-Laure Curchod, Dominique Perrin, Yingzi Xue^¶, Jason Yasenchak^¶, Ann Clark^||, Maria Chiara Magnone², Paola Zaratin, David Valenzuela^¶, Christian Rommel, and Rob Hooft van Huijsduijnen³

From the Merck Serono International, 1211 Geneva, Switzerland, Merck Serono Istituto di Ricerche Biomediche "Antoine Marxer" (RBM), Colleretto Giacosa (TO) 10010, Italy, ^¶Regeneron Pharmaceuticals, Inc. Tarrytown, New York 10591-6707, and ^||EMD Serono Research Institute, Rockland, Massachusetts 02370

Several protein-tyrosine phosphatases (PTPs) have been implicated in the control of growth hormone receptor (GHR) signaling, but none have been shown to affect growth in vivo.We have applied a battery of molecular and cellular approaches to test a family-wide panel of PTPs for interference with GHR signaling. Among the subset of PTPs that showed activity in multiple readouts, we selected PTP-H1/PTPN3 for further in vivo studies and found that mice lacking the PTP-H1 catalytic domain show significantly enhanced growth over their wild type littermates. In addition, PTP-H1 mutant animals had enhanced plasma and liver mRNA expression of insulin-like growth factor 1, as well as increased bone density and mineral content. These observations point to a controlling role for PTP-H1 in modulating GHR signaling and systemic growth through insulin-like growth factor 1 secretion.

Received for publication, July 16, 2007 , and in revised form, September 4, 2007.

^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains additional supplemental experimental protocols, figures, and results.

¹ Present address: International Institute of Molecular and Cell Biology, 02-109 Warsaw, Poland.

² Present address: Novartis Pharma AG, Basel CH-4002, Switzerland.

³ To whom correspondence should be addressed: Merck Serono International S.A., 9, chemin des Mines, 1211 Geneva, Switzerland. Tel.: 41-22-414-3000; Fax: 41-22-794-6965; E-mail: rob.hooft{at}merckserono.net.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?